AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
2
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
3
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
4
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
5
Marvell CTO: "The market has finally reached the bottleneck we solve"
More news

Weight Loss

4 stories about Weight Loss
גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer
On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%